Alimentary Pharmacology & Therapeutics

Papers
(The H4-Index of Alimentary Pharmacology & Therapeutics is 38. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Editorial: Endomysial Antibodies for a No‐Biopsy Diagnosis of Coeliac Disease—The Jury Is Still out. Authors' Reply146
Issue Information142
AP&T: Editors' Declarations of Interest130
Editorial: Breath Profiling in MASLD—A Step Towards Better Risk Stratification111
84
Issue Information84
Letter: Positivity of High‐Sensitivity HBsAg Test Was Significantly Associated With Poor Prognosis in Patients With Non‐HBV‐Related HCC81
Letter: Gut microbiota—An overlooked therapeutic target in the prevention of post‐operative recurrence of Crohn's disease73
72
Letter: Real‐Life Evaluation of Effectiveness of Mesenchymal Stem Cell Treatment in Fistulising Crohn's Disease Emphasises Importance of Appropriate Patient Selection and Centre Expertise—Authors' Rep67
Editorial: Will MRI‐PDFF become the new standard for steatosis assessment in NAFLD? Authors' reply65
Letter: Supporting the Role of Enzyme Therapy in Management of Coeliac Disease63
Editorial: Implementing Risk Assessment Tools for MetALD in Clinical Practice—Authors' Reply63
Letter: Potential confounders might exaggerate the risk of rheumatoid arthritis in patients with microscopic colitis62
59
Issue Information59
Letter: Allostatic load—A potential key in the development of inflammatory bowel disease58
Positivity of high‐sensitivity HBsAg test, not previous HBV infection, indicates poor prognosis in patients with non‐HBV‐related HCC58
Letter: Elderly onset inflammatory bowel disease—Treat to target approach is still warranted58
Editorial: Updated epidemiology of steatotic liver disease in people withHIVin the United States—Authors' reply56
Editorial: rectal hyposensitivity in patients with hypermobile Ehlers‐Danlos syndrome and constipation—authors' reply56
Editorial: switching to tenofovir alafenamide monotherapy is effective and safe for other nucleos(t)ide analogues‐treated patients with chronic hepatitis B56
Editorial: ustekinumab during pregnancy ‐ reassuring but still not enough54
Editorial: Plants against animals53
Letter: ductular reaction is a risk factor for prognosis of chronic hepatitis B complicated with non‐alcoholic fatty liver disease51
Editorial: concurrence of coeliac disease with inflammatory bowel disease – is big data the final arbiter? Authors' reply50
Letter: Ozanimod and latent tuberculosis50
Editorial: coeliac disease follow‐up guided by gluten immunogenic peptides—are we there yet? Authors' reply50
Letter: practical considerations for nonselective beta‐blocker therapy in portal hypertension49
Editorial: Inflammatory Bowel Disease and Dietary Emulsifiers—A Conundrum That Continues. Authors' Reply42
Editorial: Advanced glycation end products ‐ a dietary culprit for IBD in the genetically susceptible?42
Editorial: Can we predict or not predict response to hypnotherapy? That is the question42
Editorial: Assessing advanced fibrosis in metabolic‐associated steatotic liver disease—TheMAFLDfibrosis score42
Colorectal cancer in elderly‐onset inflammatory bowel disease: a 1969–2017 Scandinavian register‐based cohort study41
Editorial: Revisit the causes and long‐term outcomes in cirrhosis patients40
Editorial: clinical outcomes in lean NAFLD – the devil is in the details. Authors' reply39
Clinical Trial: Association Between Early Disease Clearance and Long‐Term Outcomes—4‐Year Results From the Phase 3 UNIFI Study of Ustekinumab in Ulcerative Colitis39
Development of a model to identify patients who do not need oesophageal biopsies when eosinophilic oesophagitis is suspected39
Editorial: The future of managing drug induced liver injury38
Liver resection versus microwave ablation for hepatocellular carcinoma in ideal candidates for ablation per Barcelona Clinic Liver Cancer staging: a propensity score matching and inverse probability o38
Editorial: dietary interventions to understand and treat primary sclerosing cholangitis—is gluten‐free diet a starting point?38
Clinical Trial: Effect of Abdominal Vibration Combined With Walking Exercise Programme on Bowel Preparation in Older Patients With Constipation38
Letter: Thiopurines the Silent Workhorse for Many Patients After a Flare of Ulcerative Colitis. Authors' Reply38
0.045235157012939